Hikma Pharmaceuticals PLC (LON:HIK - Get Free Report)'s share price crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 1,990.43 ($25.22) and traded as high as GBX 2,320 ($29.40). Hikma Pharmaceuticals shares last traded at GBX 2,294 ($29.07), with a volume of 287,835 shares trading hands.
Analysts Set New Price Targets
Separately, Berenberg Bank upped their target price on Hikma Pharmaceuticals from GBX 2,400 ($30.41) to GBX 2,560 ($32.44) and gave the company a "buy" rating in a report on Wednesday, January 29th.
Check Out Our Latest Research Report on HIK
Hikma Pharmaceuticals Stock Performance
The business has a fifty day moving average of GBX 2,117.77 and a 200 day moving average of GBX 1,995.97. The company has a quick ratio of 1.27, a current ratio of 1.66 and a debt-to-equity ratio of 55.82. The company has a market cap of £6.41 billion, a P/E ratio of 22.67, a P/E/G ratio of 2.38 and a beta of 0.41.
Hikma Pharmaceuticals Company Profile
(
Get Free Report)
At Hikma we help put better health within reach, every day. By creating high-quality medicines and making them accessible to the people who need them, we help to shape a healthier world that enriches all our communities. We help deliver this by living our culture, delivering our strategy, and acting responsibly.
See Also
Before you consider Hikma Pharmaceuticals, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hikma Pharmaceuticals wasn't on the list.
While Hikma Pharmaceuticals currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
